Pyxis Oncology, Inc. · NASDAQ:PYXS
Integrated Core Strategies (US) LLC's stake in Pyxis Oncology, Inc. fell to 4.00% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 6, 2025
Integrated Core Strategies (US) LLC's stake in Pyxis Oncology, Inc. fell to 4.00%, 2,484,992 shares, as a passive investor on Mar 31, 2025. Filed May 6, 2025 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 2,484,992
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 4.00% | 2,484,992 |
| Millennium Management LLC | 4.00% | 2,488,079 |
| Millennium Group Management LLC | 4.00% | 2,488,079 |
| Israel A. Englander | 4.00% | 2,488,079 |
Source
Related
- Pyxis Oncology, Inc.
- Millennium Management LLC
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Jul 10, 2026